Reduction of Acquired High Titer Factor VIII Antibodies by Extracorporeal Antibody-based Immunoadsorption without Additional Immunosuppressive Therapy

• References

• 1 Knöbl P, Derfler K, Korninger l, Kapiotis S, Jäger U, Maier-Dobersberger T, Hörl W, Lechner K, Pabinger I. Elimination of acquired factor VIII antibodies by extracorporeal antibody-based immunoadsorption (Ig-Therasorb).. Thromb Haemost 1995; 74: 1035-38.
• 2 DuMoulin A, Müller-Derlich J, Bieber F, Richter WO, Frei U, Müller R, Spaethe R. Antibody based immunoadsorption as therapeutic means.. Blood Purif 1993; 11: 145-9.
• 3 Freedman J, Semple JW, Teitel J, Stewart K, Garvey B. Clinical and immunologic effects of staphylococcal protein A immunoadsorption therapy for inhibitor of factor VIII.. Transfus Sci 1992; 13: 223-32.
• 4 Francesconi M, Korninger C, Thaler E, Niessner H, Höcker P, Lechner K. Plasmapheresis: its value in the management of patients with antibodies to factor VIII.. Haemostasis 1982; 11: 79-85.
• 5 Nilsson IM, Jonsson S, Sindquist SB, Ahlberg A, Bergenz SE. A procedure for removing high titer antibodies by extracorporeal protein A sepharose adsorption in hemophilia.. Blood 1981; 58: 38-42.
• 6 Nilsson IM, Freiburghaus C. Apheresis.. Adv Exp Med Biol 1995; 386: 175-84.
• 7 Nilsson IM, Berntorp E, Freibughaus C. Treatment of patients with factor VII and IX inhibitors.. Thromb Haemost 1993; 70: 56-9.